Metrics alone won't win markets anymore

Over the last decade, consumer health learned the language of measurement.

Sleep score. HRV. VO₂ max. Glucose. Cortisol. Steps. Recovery. Readiness. Biological age.

This felt like progress — and in many ways, it was. Consumers gained access to signals that used to be hidden behind clinical walls, lab reports, sports science departments, or medical specialists. The body became visible in a new way to everybody.

But visibility is not enough. Health doesn't come from tracking.

More data does not automatically create better results. More tracking does not automatically create better decisions. More optimization does not automatically create a more meaningful life.

This is the deeper message in Everstride’s May 2026 Consumer Health Market Briefing. The briefing argues that the wellness economy is shifting fast, and that old rules are no longer working. Optimization metrics and one-size-fits-all routines are becoming less compelling. Consumers increasingly want meaning, identity, and help while navigating modern life. The future of consumer health, the briefing suggests, is not simply about selling peak performance.

It is about building brands people actually believe in.

A market that is still expanding, but becoming more selective

Everstride’s briefing estimates the global consumer health and wellness market, defined as consumer health OTC products and personal care, excluding wellness services, real estate, and tourism, at USD 6.9 billion in 2025. It is expected to reach USD 7.2 billion in 2026 and USD 11.6 billion by 2035, implying a 5.4% compound annual growth rate — implying a structural, compounding demand.

The briefing also notes that North America dominated the consumer health market in 2025, while APAC is expected to grow the fastest until 2035. OTC pharmaceuticals held the largest market share in 2025, but personal care is projected to gain share by 2035 as consumers shift toward holistic wellness, self-care, and preventive skincare routines.  

This gives us a useful signal.

The market is not only growing. It is broadening.

Consumer health is no longer just about treating symptoms with OTC products. It is moving toward prevention, daily routines, aesthetics, self-knowledge, body composition, mental health, recovery, and identity.

This is why the term “wellness” has become both powerful and problematic.

It covers almost everything. Supplements, wearables, diagnostics, skincare, GLP-1 companion products, longevity clinics, mental health apps, functional beverages, fertility platforms, recovery tools, high-end fitness clubs, AI coaching, retreats, and communities.

That creates opportunity. But it also creates confusion.

The next phase of consumer health will not reward every company that uses the language of wellness or longevity. It will reward companies that solve a clear problem, create repeated utility, and earn trust.

From reactive care to proactive life

One of the strongest ideas in the briefing is the move from reactive care to proactive life.

Everstride frames the future as “closed-loop consumer longevity stacks” that connect data-driven health routines with subjective wellbeing. The framework includes biological signals and self-knowledge, nervous system and circadian stability, clarity and lived purpose, social reinforcement and shared norms, continuous care and coaching, and the environmental conditions people live in.  

This is a more mature view of longevity.

Health is not reduced to biomarkers. But they're also not dismissed. Instead, it places them inside a larger system.

A sleep score may tell you something.
A glucose curve may tell you something.
A VO₂ max test may tell you something.
A biological age test may tell you something.

But none of these signals, on their own, tell you what to do.

The next generation of successful consumer health products will do more than measure. They will guide their users.

Forming action into habit. Habit into identity. And identity into a life people can actually sustain.

The six-part consumer wellness ecosystem

Everstride groups the consumer wellness ecosystem into six segments: Perform, Track, Connect, Heal, Fuel, and Think. This segmentation is useful because it moves beyond product categories and asks what role a company plays in a consumer’s life.  

Perform is about physical capability. Movement, fitness, recovery, equipment, in-person performance, and the routines that help people remain active and resilient.

Track is the intelligence layer. Wearables, diagnostics, software, non-wearable devices, and monitoring tools turn the body into a stream of signals.

Connect is about belonging, relationships, communities, experiences, memberships, events, AI companionship, and social reinforcement.

Heal remains linked to traditional care systems, but with innovation around access, clinician enablement, care delivery, biotechnology, pharmaceuticals, and personalized treatment.

Fuel covers food, nutrients, VMS, functional nutrition, hormonal products, aging-focused products, and tech-forward consumer health.

Think includes mental health, mindfulness, neurotechnology, cognitive development, lifestyle software, female healthcare, and tools for self-awareness and cognitive performance.

The interesting point is not the labels themselves. The interesting point is what they reveal about the market.

Consumer health is no longer only about the body as a biological machine. The mind, the social environment, the routines, the meaning structure, and the person’s relationship with their own future become more and more part of the longevity picture.

Still, many longevity companies behave as if the market is primarily about interventions: supplements, diagnostics, drugs, tests, devices, or clinics.

But the consumer does not experience longevity as an intervention. Instead, they experience it as energy, confidence, weight, sleep, appearance, strength, mental clarity, sexual vitality, independence, and the ability to keep participating in life.

The valuation signal: Track, Think, and Connect are leading

The public market data in the briefing shows where investors are currently assigning premium value.

Everstride’s consumer wellness market index, composed of 55 companies, shows a sustained post-pandemic valuation premium. The median EV/EBITDA multiple stood at 14.5x as of April 2026, above the pre-pandemic average of 12.8x between 2016 and 2020.  

That premium is not evenly distributed.

The Think segment showed a 2025A median EV/EBITDA multiple of 22.6x, although its 2026E multiple falls sharply to 10.7x, reflecting both expected normalization and volatility in the peer group. Track traded at 16.6x 2025A EV/EBITDA and 14.5x 2026E. Connect traded at 12.6x 2025A and 12.2x 2026E.  

By contrast, Perform traded at 13.0x 2025A and 11.0x 2026E, while Fuel traded at 10.9x 2025A and 8.8x 2026E. Heal is measured on EV/Revenue rather than EV/EBITDA because many companies in that segment are not profitable due to high R&D, regulatory costs, and infrastructure scaling. Its median EV/Revenue multiple was 5.9x in 2025A and 5.4x in 2026E.  

The conclusion is clear.

Markets are rewarding the layers that create intelligence, guidance, and ongoing engagement.

That should make every longevity founder pay attention.

The highest-value consumer health companies may not be the ones that simply sell the intervention, but also own the relationship around the intervention.

The MoL view

The Everstride briefing captures something important about where consumer health is heading.

The first wave of wellness was aspirational.
The second wave was quantified.
The third wave will be integrated.

The winners will not simply sell a supplement, a test, a wearable, a clinic visit, or an app.

They will connect measurement with interpretation.
They will connect routines with identity.
They will connect protocols with coaching.
They will connect science with experience.
They will connect healthspan with the kind of life people actually want to live.

This is the deeper shift behind consumer longevity that is currently on its way.